Engineering Elastin-Like Peptide-Based Nanoparticles displaying Variable Domain of the Heavy Chain of Heavy-Chain-Only Antibodies for SARS-CoV-2 Neutralization
Biomacromolecules · 2026
DOI: 10.1021/acs.biomac.5c02042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Duc H T Le und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven 5600 MB, The Neth…. Hauptthemen laut MEDLINE: Nanoparticles, SARS-CoV-2, Elastin, Antibodies, Neutralizing. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Health~Holland.
Abstract (Originalsprache)
Elastin-like polypeptides (ELPs) are self-assembling recombinant biopolymers that can be precisely engineered to display functional targeting ligands. In this study, we developed ELP-based nanoparticles (NPs) displaying the variable domain of the heavy chain of heavy-chain-only antibodies (VHHs) targeting the SARS-CoV-2 spike protein. By tuning VHH selection, multivalency, and surface display density, we created targeted ELP NPs capable of blocking entry of spike-protein-presenting virus-like particles (VLPs) and live viruses, with subnanomolar IC50 values, significantly outperforming the monovalent VHH equivalents. Notably, optimizing multivalency and VHH density unlocked broad virus-neutralizing potency against multiple variants, including Omicron variants resistant against the monovalent VHH equivalents. Confocal imaging further revealed that VHH-ELP NPs formed aggregates with VLPs, enhancing uptake by M1 macrophages, suggesting potential for eliciting vaccinal effects. Overall, this work highlights the versatility of ELP NPs as a tunable antiviral platform and provides design principles for next-generation nanotherapeutics against evolving viral threats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven 5600 MB, The Netherlands.
- Department of Medical BioSciences, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.
- Department of Medical Microbiology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.
- MindWalk, Austin, 78701Texas ,United States.
- ImmunoPrecise Antibodies (Europe) B.V., Oss, 5349 ABThe Netherlands.
ORCID-Profile: Duc H T Le, Jan C M van Hest, Wouter P R Verdurmen
Förderung
- Health~Holland
Zitieren
APA
Le, D. H. T., van Oostrum, J., van de Westerlo, E., Wang, J., Overheul, G. J., van Rij, R. P., Leenders, W. P. J., Bijlsma, J., Roodink, I., van Hest, J. C. M., & Verdurmen, W. P. R. (2026). Engineering Elastin-Like Peptide-Based Nanoparticles displaying Variable Domain of the Heavy Chain of Heavy-Chain-Only Antibodies for SARS-CoV-2 Neutralization. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c02042
Vancouver
Le DHT, van Oostrum J, van de Westerlo E, Wang J, Overheul GJ, van Rij RP, et al. Engineering Elastin-Like Peptide-Based Nanoparticles displaying Variable Domain of the Heavy Chain of Heavy-Chain-Only Antibodies for SARS-CoV-2 Neutralization. Biomacromolecules. 2026. doi:10.1021/acs.biomac.5c02042
BibTeX
@article{Le2026,
author = {Le, Duc H T and van Oostrum, Jenny and van de Westerlo, Els and Wang, Jianhong and Overheul, Gijs J and van Rij, Ronald P and Leenders, William P J and Bijlsma, Jetta and Roodink, Ilse and van Hest, Jan C M and Verdurmen, Wouter P R},
title = {Engineering Elastin-Like Peptide-Based Nanoparticles displaying Variable Domain of the Heavy Chain of Heavy-Chain-Only Antibodies for SARS-CoV-2 Neutralization},
journal = {Biomacromolecules},
year = {2026},
doi = {10.1021/acs.biomac.5c02042}
}
EUVIMED